Cell Signaling Technology to Conduct Pilot Study for AstraZeneca to Find Biomarkers of Target Inhibition

genomeweb
360dx

Cell Signaling Technology to Conduct Pilot Study for AstraZeneca to Find Biomarkers of Target Inhibition

Jun 08, 2004

NEW YORK, June 8 (GenomeWeb News) - Cell Signaling Technology will perform a pilot study for AstraZeneca to find biomarkers of target inhibition using its phospho-proteomics technology, the company said yesterday.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Grifols Gets FDA Clearance for Two Blood Screening Assays on Procleix Panther System
Natera, Institut Jules Bordet Ink Breast Cancer Research Collaboration
US Department of Defense Awards GeneCapture $1M Contract
Health Canada Approves Hologic Panther Fusion System; Flu, Respiratory Assays
Data Analytics Startup Elucidata Raises $1.7M in Seed Funding
Single-Cell Analysis Elucidates Epigenetic Changes in Early Human Development

The Scan

Theranos' Holmes Indicted

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Mixed Reaction

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

Already Used

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

This Week in PLOS

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more

Main menu